Kayser, Reilly R. MD; Raskin, Marissa BS; Snorrason, Ivar PhD; Hezel, Dianne M. PhD; Haney, Margaret PhD; Simpson, Helen Blair MD, PhD
Journal of Clinical Psychopharmacology: February 14, 2020 – Volume Publish Ahead of Print – Issue –
doi: 10.1097/JCP.0000000000001179
“Taken together, these findings suggest that agents targeting elements of the ECS (cannabinoids) could modulate the aforementioned neurocognitive processes to improve OCD symptoms.”
